fashion -WSS

fashion

author：entertainment 2025-09-03 03:39:20 - browse：438

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Class action alleges UnitedHealth concealed DOJ probe

hotspot

WSS

Deliver public health messages at the right time

Crowdfunding for medical bills sidesteps core problem, author says

Sanofi CEO defends move to abandon profit guidance, boost research

AltruBio raises $225 million to develop ulcerative colitis drug

MoonLake credibility takes another hit with mid

As billionaires fund anti

hotspot

fashion

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Class action alleges UnitedHealth concealed DOJ probe

Guidelines to prevent youth baseball injuries need more muscle

Sanofi CEO defends move to abandon profit guidance, boost research

Walensky prepares to leave CDC — and Congress — behind

Brain MRIs reveal impact of 'toxic stress' on Black children

Alkermes shareholders re

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Apple is now the first public company to be valued at $3 trillion

Extreme heat events are a public health emergency

explore

10 million people disenrolled from Medicaid over past six months

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Warren pushes Witty on UnitedHealth's control over physicians

Crowdfunding for medical bills sidesteps core problem, author says

Senate panel clears PBM, hopsital reforms

AI for drug discovery: Experts on separating hype from reality

knowledge

hotspot

hotspot

hotspot